drug
duloxetine hydrochloride DR
Marketedupdated 3mo agoby Qingdao Baheal Medical Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3indications
investigational
Major Depression
all catalysts(12)
approval · 12
Jun 9, 2014
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 27, 2026
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Apr 9, 2026
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Trials studying duloxetine hydrochloride DR
- phase2A Phase II Study to Evaluate NH102 for Depression
- phase3Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder
- phase2A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression
- —Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 13, 2037
~10.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (20)
- Apr 13, 2037formulationUS 10413525
- Apr 13, 2037formulationUS 10413525
- Apr 13, 2037formulationUS 10413525
- Apr 13, 2037formulationUS 10413525
- Apr 13, 2037formulationUS 10959982
- Apr 13, 2037formulationUS 10959982
- Apr 13, 2037formulationUS 10959982
- Apr 13, 2037formulationUS 10959982
- Apr 13, 2037formulationUS 11202772
- Apr 13, 2037formulationUS 11202772
- Apr 13, 2037formulationUS 11202772
- Apr 13, 2037formulationUS 11202772
- Apr 13, 2037formulationUS 12171742
- Apr 13, 2037formulationUS 12171742
- Apr 13, 2037formulationUS 12171742
- Apr 13, 2037formulationUS 12171742
- Apr 13, 2037formulationUS 9839626
- Apr 13, 2037formulationUS 9839626
- Apr 13, 2037formulationUS 9839626
- Apr 13, 2037formulationUS 9839626
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that